Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ravit Agassi"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Invasive breast cancer (IBC) is a leading cause of cancer-related death among women in Israel, regardless of ethnicity. This study compared IBC epidemiological, clinical, and pathological characteristics in Bedouin and Jewish pati
Externí odkaz:
https://doaj.org/article/65f8ff57650a455faea1b17c56c4d8e5
Autor:
Ao Wang, Elchanan Quint, Ivan Kukeev, Ravit Agassi, Olga Belochitski, Gay Barski, Julie Vaynshtein
Publikováno v:
International Journal of Breast Cancer, Vol 2024 (2024)
Conclusion: Our findings suggest that IORT in selected low-risk patients can achieve an excellent prognosis with low rates of recurrence and metastasis.
Externí odkaz:
https://doaj.org/article/98c8d7018f934bc283cbff3e0c9b8925
Autor:
Martins Otikovs, Noam Nissan, Edna Furman-Haran, Debbie Anaby, Ravit Agassi, Miri Sklair-Levy, Lucio Frydman
Publikováno v:
Diagnostics, Vol 13, Iss 23, p 3516 (2023)
Quantitative correlations between T2 and ADC values were explored on cancerous breast lesions using spatiotemporally encoded (SPEN) MRI. To this end, T2 maps of patients were measured at more than one b-value, and ADC maps at several echo time values
Externí odkaz:
https://doaj.org/article/c27adde6e7684b8188f1d76c685953a4
Autor:
Noam Nissan, Alexey Kulpanovich, Ravit Agassi, Tanir Allweis, Ilana Haas, Einat Carmon, Edna Furman-Haran, Debbie Anaby, Miri Sklair-Levy, Assaf Tal
Publikováno v:
European Radiology. 33:3744-3753
Background: Invasive Breast Cancer (IBC) is a leading cause of cancer-related death among women in Israel, regardless of ethnicity. This study compared IBC epidemiological, clinical, and pathological characteristics in Bedouin and Jewish patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c55f8af64505e8b44f9db0d5552e2e3f
https://doi.org/10.21203/rs.3.rs-2820426/v1
https://doi.org/10.21203/rs.3.rs-2820426/v1
Autor:
Miri Sklair-Levy, Tanir M. Allweis, Debbie Anaby, Lucio Frydman, Ravit Agassi, Noam Nissan, Martins Otikovs, Edna Furman-Haran
Publikováno v:
Journal of Magnetic Resonance Imaging. 53:1913-1925
Diffusion-weighted imaging (DWI) can improve breast cancer characterizations, but often suffers from low image quality -particularly at informative b > 1000 s/mm2 values. The aim of this study was to evaluate multishot approaches characterizing Gauss
Autor:
Yuval Mizrakli, Amos Douvdevani, Maia Rosenthal, Victor Novack, Samuel Ariad, Ravit Agassi, Reut Riff, Shaked Yarza, David Czeiger, Irena Lazarev, Michal Peled
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Mammography has a crucial role in the detection of breast cancer (BC), yet it is not limitation-free. We hypothesized that the combination of mammography and cell-free DNA (cfDNA) levels may better discriminate patients with cancer. This prospective
Autor:
Lisi M. Dredze, Michael Friger, Samuel Ariad, Michael Koretz, Bertha Delgado, Ruthy Shaco-Levy, Margarita Tokar, Michael Bayme, Ravit Agassi, Maia Rosenthal, Victor Dyomin, Olga Belochitski, Shai Libson, Tamar Mizrahi, David B. Geffen
Publikováno v:
Breast cancer research and treatment. 193(3)
We analyzed outcomes of doxorubicin-cyclophosphamide (AC) followed by weekly paclitaxel as neoadjuvant chemotherapy (NAC) for breast cancer (BC), in an everyday practice with long-term follow-up of patients.All patients (n = 200) who received the AC-
Autor:
Martins, Otikovs, Noam, Nissan, Edna, Furman-Haran, Debbie, Anaby, Tanir M, Allweis, Ravit, Agassi, Miri, Sklair-Levy, Lucio, Frydman
Publikováno v:
Journal of magnetic resonance imaging : JMRIReferences. 53(6)
Diffusion-weighted imaging (DWI) can improve breast cancer characterizations, but often suffers from low image quality -particularly at informative b 1000 s/mm
Autor:
Gad Shaked, David Czeiger, Konstantin Lavrenkov, Amos Douvdevani, Avital Avriel, Samuel Ariad, Jony Sheynin, Ravit Agassi
Publikováno v:
American Journal of Clinical Pathology. 143:18-24
Objectives: To evaluate circulating cell-free DNA (CFD) measured by a simple fluorescent assay as a biomarker of breast cancer. Methods: We enrolled 38 patients with breast cancer before surgery, two patients with noncancerous breast lesions, nine pa